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ABSTRACT 
Currently, 14% of the human proteome is made up of proteins whose existence is not confirmed 
by mass spectrometry. We performed a proteomic profiling of human mesenchymal stem cells 
(hMSCs) derived from adipose tissue or umbilical cord and identified peptides derived from 13 
of such missing proteins. Remarkably, we found compelling evidence for the expression of 
hyaluronan synthase 1 (NX_Q92839-1) and confirmed its identification by the fragmentation of 
4 heavy-labeled peptides that coeluted with their endogenous light counterparts. Our data also 
suggest that hMSCs constitute a promising source for the detection of missing proteins.  
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Human mesenchymal Stem Cells (hMSCs) are multipotent stromal cells that can be isolated from 
a number of tissues and organs such as umbilical cord, bone marrow, liver, muscle, adipose 
tissue or peripheral blood (1). Because of their well-established capacity for tissue repair, they 
are employed in regenerative medicine, mainly in clinical trials. In addition, they show great 
promise for the treatment of autoimmune diseases due to their unique immunomodulatory 
potential (2). For these reasons, there is growing interest in the study of hMSCs and, in 
particular, in the elucidation of the molecular mechanisms that determine their biological 
properties.  
We performed a large-scale shotgun analysis of these cells in the context of a research project 
involving the proteomic profiling of hMSCs derived from umbilical cord or adipose tissue. Since 
hMSCs are undifferentiated cells (1), we reasoned that they could be a good source for the 
identification of missing proteins as they could express genes that are repressed in normal adult 
tissues. This letter summarizes our findings in this regard and aims to highlight the potential of 
hMSCs for the detection of missing proteins. 
A detailed description of the methods employed can be found in Supplemental Information S1. 
In brief, we lysed about 107 hMSCs derived from adipose tissue or umbilical cord. After 
precipitation, we subjected the proteins to two different analytical workflows. First, we 
fractionated the proteins by SDS-PAGE and performed an in-gel digestion with trypsin of the 
resulting 14 gel slices. After peptide extraction, we analyzed the samples by LC-MS/MS using a 
Q Exactive HF mass spectrometer (Thermo Fisher). In the second approach, we performed a 
trypsin digestion and peptides were resolved by high pH reversed phase chromatography. We 
collected 6 chromatographic fractions that, together with an aliquot of the unfractionated 
sample, were analyzed by LC-MS/MS in a 5600 Triple-TOF mass spectrometer (Sciex). 
We searched the acquired MS/MS spectra against the last release available of the neXtProt 
database (v2.15.0; 2018-01-17) using an in-house developed algorithm that combines the 
outputs of four independent search engines (3, 4): MASCOT (5), X! Tandem (6), OMSSA (7) and 
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Myrimatch (8). Identifications were filtered at a FDR ≤ 1% at the protein level. It must be noted 
that FDR estimation is based on several imperfect assumptions and, thus, not all proteins 
surpassing this threshold are confidently identified.   
The number of protein hits varied between 4616 and 6202 depending on the origin of the hMSCs 
and the analytical workflow. Not surprisingly, the analysis performed in the Q Exactive platform 
after SDS-PAGE separation resulted in a 20% (umbilical cord) and 28% (adipose tissue) increase 
in protein matches, likely reflecting the higher performance of this mass spectrometer and the 
more extensive fractionation of the samples (Table 1).  
Next, we queried these lists of identifications for the presence of missing proteins. We used the 
neXtProt peptide uniqueness checker (9) to determine which of the sequences assigned to 
missing proteins were unique, taking into account all known sequence variation arising from 
single amino acid substitutions. 13 candidates survived this stringent filtering (Figure 1). We 
gathered evidence for the presence of 5 and 11 missing proteins in the adipose tissue and the 
umbilical cord samples respectively. All in all, the overlap between the four datasets was low, 
and most of the matches relied on a single unique peptide. Nevertheless, we noticed that one 
of the proteins –Hyaluronan synthase 1 (NX_Q92839-1)– was detected in 3 of the 4 datasets 
(Figure 1). Furthermore, this identification was supported by 6 different peptide sequences 
(Table 2 and Supplemental Information S2). The expression of Hyaluronan synthase 1 was 
particularly evident in the adipose tissue-derived hMSCs where it was identified with 5 different 
tryptic peptides. 
Since 4 of the sequences in this set are of at least 9 amino acids in length, the detection of this 
missing protein is validated according to the HPP data interpretation guidelines 2.1 (10). 
However, for further confirmation, we set out to synthesize 5 of the identified peptides 
isotopically labeled with 13C6 15N4 Arginine (+10 Da) at the C-terminus. We ruled out the longest 
one (ACQSYFHCVSCSGPLGLYR, 20 residues long) to avoid problems during solid phase synthesis. 
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These 5 heavy standards were spiked into tryptic digests of umbilical cord or adipose tissue-
derived hMSCs and the resultant mixture was analyzed by parallel reaction monitoring (PRM) in 
both the Q Exactive and the 5600 Triple TOF platforms. This analysis proved that, with only one 
exception (LAVEALVR), all the light peptides coeluted with their heavy counterparts 
(Supplemental Information S3). In agreement with the shotgun analysis, hyaluronan synthase 1 
was identified with much more confidence in the extract of hMSCs derived from adipose tissue. 
Regarding this latter point, only 1 endogenous peptide (LDPMALLELVR) was detected in 
umbilical cord-derived hMSCs, and exclusively in the analysis performed in the Q Exactive mass 
spectrometer (Supplemental Information S3). This observation is probably indicative of 
differential regulation of HAS1 expression between both cells. 
It is worth noting that one of the peptides identified in the shotgun analysis (LAVEALVR) failed 
to coelute with its labeled counterpart despite having very similar MS/MS spectra (Supplemental 
Information S4). In our opinion, the most likely explanation to this fact is that the endogenous 
species corresponds to the peptide LAVEAVLR derived from the beta subunit of the CCT 
chaperone complex (NX_P78371). Both sequences are very similar and differ only in the order 
of residues 6 and 7, which accounts for the small shift in retention time. Furthermore, the 
alternative sequence matches better with the MS/MS spectrum, as this shows signals 
compatible with the daughter ions y2+, y2+-17 and b6+ (Supplemental Information S4). Whatever 
the explanation, this example highlights the need of confirming peptide detection claims with 
SRM/PRM experiments using labeled standards and not only by fragmentation of the 
corresponding synthetic peptides. Thus, we propose that this sort of verification should be 
mandatory for reporting the identification of missing proteins in the context of the Human 
Proteome Project. 
Hyaluronan synthase 1 (EC 2.4.1.212) is encoded by the HAS1 gene and belongs to a family of 
three isozymes that participate in the synthesis of hyaluronic acid, catalyzing the addition of N-
acetylglucosamine or glucuronic acid to the nascent polymer (11). The identification of this 
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enzyme in the proteome of hMSCs is not completely unexpected as mRNA levels of HAS1 are 
relatively high in bone marrow-derived hMSCs (12). It is likely that this is also the case also for 
cells of different origins because the hyaluronan receptor CD44 is a positive marker of stemness 
and the interaction of hMSCs with the extracellular matrix is critical for their physiological 
function (1).  
Considering its well stablished physiological function and its extensive annotation, the lack of 
MS-based evidence for hyaluronan synthase 1 in the literature seems surprising. Possibly, the 
localization of this protein at the cell membrane –dictated by the presence of 7 transmembrane 
regions– poses a drawback to its efficient extraction and solubilization, hampering its 
identification by standard proteomic workflows. Anyhow, here we demonstrate the expression 
of HAS1 at the protein level so that it should no longer be considered a missing protein. Besides, 
the 4 peptides validated in this work here are ideal targets for the development of PRM/MRM 
methods. Finally, we provide suggestive evidence of the presence of 12 additional missing 
proteins that deserve further analysis for their confirmation, indicating that hMSCs may 
constitute a good model to gain insight into this hidden portion of the human proteome. 
ASSOCIATED CONTENTS 
S1. Materials and methods. 
S2. Annotated MS/MS spectra of the tryptic peptides mapping to hyaluronan synthase 1.  
S3. PRM analysis of 5 tryptic peptides derived from hyaluronan synthase 1. 
S4. Extracted ion chromatograms and MS/MS spectra of the peptides LAVEALVR[+10] and 
LAVEAVLR. 
AUTHOR INFORMATION 
Corresponding Author 
b Miguel Marcilla. Phone: (+34) 91 5854540, Fax: (+34) 91 5854506, Email address: 
mmarcilla@cnb.csic.es 
Present Address 
6 
 
Centro Nacional de Biotecnología. Darwin 3. 28049. Madrid, Spain. 
Notes 
a Equal contribution. 
ACKNOWLEDMENTS 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral. proteomexchange.org) via the PRIDE partner repository 
with the data set identifier PXD009893. The Proteomics Units of the Spanish National 
Biotechnology Centre and of the Complutense University of Madrid belong of Proteored-ISCIII 
and are supported by grant PT17/0019 of the PE I+D+i 2013-2016, funded by ISCIII and ERDF.  
The Andalusian Public Health System Biobank is part of the National Bank of Stem Cell Lines 
(BNLC-ISCIII) and is also supported by the above-mentioned grant. 
REFERENCES 
1. Assis-Ribas, T.; Forni, M. F.; Winnischofer, S. M. B.; Sogayar, M. C.; Trombetta-Lima, M., 
Extracellular matrix dynamics during mesenchymal stem cells differentiation. Dev Biol 2018, 
437, (2), 63-74. 
2. Sharma, R. R.; Pollock, K.; Hubel, A.; McKenna, D., Mesenchymal stem or stromal cells: 
a review of clinical applications and manufacturing practices. Transfusion 2014, 54, (5), 1418-37. 
3. Alpizar, A.; Marino, F.; Ramos-Fernandez, A.; Lombardia, M.; Jeko, A.; Pazos, F.; 
Paradela, A.; Santiago, C.; Heck, A. J.; Marcilla, M., A Molecular Basis for the Presentation of 
Phosphorylated Peptides by HLA-B Antigens. Mol Cell Proteomics 2017, 16, (2), 181-193. 
4. Ramos-Fernandez, A.; Paradela, A.; Navajas, R.; Albar, J. P., Generalized method for 
probability-based peptide and protein identification from tandem mass spectrometry data and 
sequence database searching. Mol Cell Proteomics 2008, 7, (9), 1748-54. 
5. Koenig, T.; Menze, B. H.; Kirchner, M.; Monigatti, F.; Parker, K. C.; Patterson, T.; Steen, J. 
J.; Hamprecht, F. A.; Steen, H., Robust prediction of the MASCOT score for an improved quality 
assessment in mass spectrometric proteomics. J Proteome Res 2008, 7, (9), 3708-17. 
7 
 
6. Craig, R.; Beavis, R. C., TANDEM: matching proteins with tandem mass spectra. 
Bioinformatics 2004, 20, (9), 1466-7. 
7. Geer, L. Y.; Markey, S. P.; Kowalak, J. A.; Wagner, L.; Xu, M.; Maynard, D. M.; Yang, X.; 
Shi, W.; Bryant, S. H., Open mass spectrometry search algorithm. J Proteome Res 2004, 3, (5), 
958-64. 
8. Tabb, D. L.; Fernando, C. G.; Chambers, M. C., MyriMatch: highly accurate tandem mass 
spectral peptide identification by multivariate hypergeometric analysis. J Proteome Res 2007, 6, 
(2), 654-61. 
9. Schaeffer, M.; Gateau, A.; Teixeira, D.; Michel, P. A.; Zahn-Zabal, M.; Lane, L., The 
neXtProt peptide uniqueness checker: a tool for the proteomics community. Bioinformatics 
2017, 33, (21), 3471-3472. 
10. Deutsch, E. W.; Overall, C. M.; Van Eyk, J. E.; Baker, M. S.; Paik, Y. K.; Weintraub, S. T.; 
Lane, L.; Martens, L.; Vandenbrouck, Y.; Kusebauch, U.; Hancock, W. S.; Hermjakob, H.; 
Aebersold, R.; Moritz, R. L.; Omenn, G. S., Human Proteome Project Mass Spectrometry Data 
Interpretation Guidelines 2.1. J Proteome Res 2016, 15, (11), 3961-3970. 
11. Itano, N.; Sawai, T.; Yoshida, M.; Lenas, P.; Yamada, Y.; Imagawa, M.; Shinomura, T.; 
Hamaguchi, M.; Yoshida, Y.; Ohnuki, Y.; Miyauchi, S.; Spicer, A. P.; McDonald, J. A.; Kimata, K., 
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol 
Chem 1999, 274, (35), 25085-92. 
12. Qu, C.; Rilla, K.; Tammi, R.; Tammi, M.; Kroger, H.; Lammi, M. J., Extensive CD44-
dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells 
produced by hyaluronan synthases HAS1, HAS2 and HAS3. Int J Biochem Cell Biol 2014, 48, 45-
54. 
 
  
8 
 
FIGURE CAPTIONS 
Figure 1. Putative missing proteins identified in extracts of adipose tissue and umbilical cord-
derived hMSCs. The proteins in the upper row were detected (green squares) or not (red 
squares) after LC-MS/MS analysis of the samples described on the left column. The numbers 
inside the green squares indicate the number of unique peptides identified in each case.  
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Table 1. Protein identifications after LC-MS/MS analysis of hMSCs. 
Dataset FDRPSM FDRpept FDRprot PSMs Peptides Proteins 
Protein 
Groups 
Adipose Tissue 
(RP-QTOF) 0.25% 0.51% 1.00% 105 065 34 887 4616 4166 
Umbilical Cord 
(RP-QTOF) 0.22% 0.49% 1.00% 121 147 41 186 5160 4660 
Adipose Tissue 
(PAGE-Orbitrap) 0.17% 0.48% 1.00% 288 536 54 382 5943 5274 
Umbilical Cord 
(PAGE-Orbitrap) 0.22% 0.47% 1.00% 295 020 60 787 6202 5482 
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Table 2. Unique peptides mapped to Hyaluronan synthase 1 (NX_Q92839-1). a AT: Adipose 
Tissue. b UC: Umbilical Cord.  
Peptide m/z z 
ATa 
Triple TOF 
UCb 
 Triple TOF 
ATa 
Q Exactive 
UCb 
Q Exactive Confirmed 
AcQSYFHcVScISGPLGLYR 792.36 3+ + - - - Not tested 
LDPMALLELVR 635.37 2+ + - + - Yes 
GPLDAATAR 436.24 2+ + - + - Yes 
YWVAFNVER 592.30 2+ + - - - Yes 
ADWSGPSR 438.20 2+ + - - - Yes 
LAVEALVR 435.77 2+ - + - - No 
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FIGURE 1
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